Canada Plans Sweeping Reforms Of Drug Patent Laws

Law360, New York (December 12, 2004, 12:00 AM EST) -- In a sweeping overhaul of Canadian drug patent laws designed to cut back on litigation, the federal government is planning reforms that will limit patent evergreening but expand data protection.

Health Minister Ujjal Dosanjh and Industry Minister David Emerson are expected to formally announce the proposals on Monday, in an effort to strike a balance between the demands of the research-based drug industry and calls for more affordable medicines.

Details of the proposal became available over the weekend in the online edition of the Canada Gazette,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.